Procter & Gamble Health Ltd. | Industrials
₹5,921.00
1.12%
| Procter & Gamble Stock Comparison:

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 11.3B
Gross Profit 7.7B 68.17%
Operating Income 2.8B 24.71%
Net Income 2.0B 17.79%
EPS (Diluted) ₹121.00

Balance Sheet Metrics

Total Assets 7.9B
Total Liabilities 2.6B
Shareholders Equity 5.4B
Debt to Equity 0.48

Cash Flow Metrics

Operating Cash Flow 3.2B
Free Cash Flow 2.1B

Revenue & Profitability Trend

Procter & Gamble Income Statement From 2018 to 2024

Metric 2024 2023 2022 2021 2018
Revenue 11.3B 12.3B 11.1B 9.9B 8.2B
Cost of Goods Sold 3.6B 3.6B 3.4B 3.4B 2.9B
Gross Profit 7.7B 8.7B 7.7B 6.5B 5.3B
Operating Expenses 2.7B 3.4B 4.9B 2.7B 2.8B
Operating Income 2.8B 3.0B 2.4B 2.3B 1.3B
Pre-tax Income 2.7B 3.1B 2.5B 2.3B 1.6B
Income Tax 723.4M 847.3M 608.5M 564.8M 562.4M
Net Income 2.0B 2.3B 1.9B 1.8B 8.4B
EPS (Diluted) ₹121.00 ₹138.23 ₹115.98 ₹107.00 ₹505.00

Income Statement Trend

Procter & Gamble Balance Sheet From 2018 to 2024

Metric 2024 2023 2022 2021 2018
Assets
Current Assets 5.2B 8.0B 6.1B 7.3B 15.3B
Non-Current Assets 2.7B 3.1B 2.8B 2.6B 2.3B
Total Assets 7.9B 11.0B 8.9B 9.9B 17.6B
Liabilities
Current Liabilities 2.2B 3.0B 2.4B 2.4B 1.9B
Non-Current Liabilities 372.1M 464.0M 414.0M 434.8M 265.4M
Total Liabilities 2.6B 3.5B 2.8B 2.8B 2.2B
Equity
Total Shareholders Equity 5.4B 7.5B 6.2B 7.0B 15.4B

Balance Sheet Composition

Procter & Gamble Cash Flow Statement From 2018 to 2024

Metric 2024 2023 2022 2021 2018
Operating Activities
Net Income 2.7B 3.1B 2.5B 2.3B 11.4B
Operating Cash Flow 3.2B 2.1B 2.0B 2.6B 10.4B
Investing Activities
Capital Expenditures -217.3M -424.8M -379.2M -525.8M -265.4M
Investing Cash Flow -194.9M -356.9M -354.2M -493.5M 12.5B
Financing Activities
Dividends Paid -4.1B -937.9M -2.8B -3.8B -249.7M
Financing Cash Flow -4.1B -937.9M -2.8B -3.8B -301.2M
Free Cash Flow 2.1B 1.9B 1.3B 1.9B -1.6B

Cash Flow Trend

Procter & Gamble Key Financial Ratios

No financial ratio data available.

Financial data is updated regularly. All figures are in the company's reporting currency.